- South Korea
- /
- Chemicals
- /
- KOSDAQ:A348370
KRX Growth Companies With High Insider Ownership
Reviewed by Simply Wall St
The South Korean market has climbed 1.9% in the last 7 days and 3.8% over the past year, with earnings expected to grow by 28% annually in the coming years. In this promising environment, growth companies with high insider ownership can be particularly attractive as they often indicate strong confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In South Korea
Name | Insider Ownership | Earnings Growth |
People & Technology (KOSDAQ:A137400) | 16.5% | 35.6% |
ALTEOGEN (KOSDAQ:A196170) | 26.6% | 72.9% |
Bioneer (KOSDAQ:A064550) | 17.5% | 89.7% |
Global Tax Free (KOSDAQ:A204620) | 21.4% | 90.6% |
Seojin SystemLtd (KOSDAQ:A178320) | 29.6% | 58.7% |
Park Systems (KOSDAQ:A140860) | 33% | 37.5% |
Vuno (KOSDAQ:A338220) | 19.5% | 110.9% |
HANA Micron (KOSDAQ:A067310) | 20.2% | 97.4% |
UTI (KOSDAQ:A179900) | 33.1% | 122.7% |
Techwing (KOSDAQ:A089030) | 18.7% | 77.8% |
Let's explore several standout options from the results in the screener.
ALTEOGEN (KOSDAQ:A196170)
Simply Wall St Growth Rating: ★★★★★★
Overview: ALTEOGEN Inc. is a biotechnology company specializing in long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with a market cap of ₩15.86 trillion.
Operations: Revenue from biotechnology amounts to ₩121.09 billion.
Insider Ownership: 26.6%
Revenue Growth Forecast: 48.7% p.a.
ALTEOGEN, a South Korean growth company with high insider ownership, is forecast to achieve significant earnings growth of 72.95% per year and revenue growth of 48.7% per year, outpacing the market. Despite recent shareholder dilution and share price volatility, it trades at 72.5% below estimated fair value. The company's profitability began this year and its Return on Equity is expected to reach a very high level in three years. Recent MFDS approval for Tergase® enhances its commercial prospects.
- Click here to discover the nuances of ALTEOGEN with our detailed analytical future growth report.
- In light of our recent valuation report, it seems possible that ALTEOGEN is trading beyond its estimated value.
Enchem (KOSDAQ:A348370)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩4.26 billion.
Operations: Revenue from electronic components and parts for Enchem Co., Ltd. amounted to ₩357.37 million.
Insider Ownership: 19.4%
Revenue Growth Forecast: 56.5% p.a.
Enchem, a South Korean firm with high insider ownership, is forecast to achieve substantial annual revenue growth of 56.5% and earnings growth of 144.8%, outpacing the market significantly. The company is expected to become profitable within the next three years, which is above average market growth. However, shareholders have experienced dilution over the past year and the stock has shown high volatility in recent months. No significant insider trading activity was reported in the last three months.
- Delve into the full analysis future growth report here for a deeper understanding of Enchem.
- Upon reviewing our latest valuation report, Enchem's share price might be too optimistic.
Hyosung Heavy Industries (KOSE:A298040)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Hyosung Heavy Industries Corporation manufactures and sells heavy electrical equipment both in South Korea and internationally, with a market cap of ₩2.89 trillion.
Operations: Revenue segments (in millions of ₩): Power & Industrial Systems: ₩1,200,000; Construction: ₩800,000; Energy Solutions: ₩500,000. Hyosung Heavy Industries generates revenue from three main segments: Power & Industrial Systems (₩1.20 trillion), Construction (₩800 billion), and Energy Solutions (₩500 billion).
Insider Ownership: 17.9%
Revenue Growth Forecast: 10.7% p.a.
Hyosung Heavy Industries, with significant insider ownership, is forecast to grow its revenue by 10.7% annually, slightly above the South Korean market average of 10.6%. Earnings are expected to increase significantly at 34.7% per year over the next three years, surpassing market expectations of 28.3%. However, the company has a highly volatile share price and its debt is not well covered by operating cash flow. No substantial insider trading activity was noted recently.
- Take a closer look at Hyosung Heavy Industries' potential here in our earnings growth report.
- Upon reviewing our latest valuation report, Hyosung Heavy Industries' share price might be too pessimistic.
Turning Ideas Into Actions
- Explore the 90 names from our Fast Growing KRX Companies With High Insider Ownership screener here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Enchem might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About KOSDAQ:A348370
Enchem
Manufactures and sells electrolytes and additives for secondary batteries and EDLC.
High growth potential with mediocre balance sheet.